BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coyle J, Rogers A, Copland R, De Paoli G, MacDonald TM, Mackenzie IS; of the Trials@Home Consortium. Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders. Br J Clin Pharmacol 2021. [PMID: 34296777 DOI: 10.1111/bcp.15003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 van Rijssel TI, de Jong AJ, Santa-Ana-Tellez Y, Boeckhout M, Zuidgeest MGP, van Thiel GJMW; Trials@Home Consortium. Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics review. Drug Discov Today 2022:S1359-6446(22)00296-3. [PMID: 35870693 DOI: 10.1016/j.drudis.2022.07.011] [Reference Citation Analysis]
2 Le Prell CG, Brewer CC, Campbell KCM. The audiogram: Detection of pure-tone stimuli in ototoxicity monitoring and assessments of investigational medicines for the inner ear. The Journal of the Acoustical Society of America 2022;152:470-90. [DOI: 10.1121/10.0011739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Garjani A, Liu BJ, Allen CM, Gunzler DD, Gerry SW, Planchon SM, das Nair R, Chataway J, Tallantyre EC, Ontaneda D, Evangelou N. Decentralised clinical trials in multiple sclerosis research. Mult Scler 2022;:13524585221100401. [PMID: 35735014 DOI: 10.1177/13524585221100401] [Reference Citation Analysis]
4 Cagnazzo C. New trends in clinical trials—between complexity and the need for renewal. abtpn 2022;9:42-44. [DOI: 10.33393/ao.2022.2437] [Reference Citation Analysis]
5 de Jong AJ, van Rijssel TI, Zuidgeest MGP, van Thiel GJMW, Askin S, Fons-Martínez J, De Smedt T, de Boer A, Santa-Ana-Tellez Y, Gardarsdottir H; Trials@Home Consortium. Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' Perspective. Clin Pharmacol Ther 2022. [PMID: 35488483 DOI: 10.1002/cpt.2628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Gamble E, Linehan C, Heavin C. Establishing requirements for technology to support clinical trial retention: a systematic scoping review and analysis using self-determination theory (Preprint).. [DOI: 10.2196/preprints.38159] [Reference Citation Analysis]
7 Naz-mclean S, Kim A, Zimmer A, Laibinis H, Lapan J, Tyman P, Hung J, Kelly C, Nagireddy H, Narayanan-pandit S, Mccarthy M, Ratnaparkhi S, Rutherford H, Patel R, Dryden-peterson S, Hung DT, Woolley AE, Cosimi LA. Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study.. [DOI: 10.1101/2021.10.28.21265624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]